Colby Jordan simultaneously serves as both an LP (Managing Director & Chief Investment Officer at Ulysses Diversified Holdings family office) and GP (venture partner at New North Ventures), giving him dual perspectives on how institutional capital thinks about venture exposure and how founders experience investors. He has cross-domain experience in life sciences platform work as Vice President at Alloy Therapeutics and their investment arm 82VS, which is uncommon for a national-security-focused venture investor.